WS #12247

From 500 msgs · 5 key-dev
Holding: newest synthesis is 124d 14h old

FDA approved Merck's first-in-class oral PCSK9 inhibitor Lipfendra for cholesterol, threatening Amgen's injectable PCSK9 franchise and potentially reshaping the lipid-lowering market.

FDA Approves Merck Oral PCSK9 Pill

FDA approved Merck's first-in-class oral PCSK9 inhibitor Lipfendra for cholesterol, threatening Amgen's injectable PCSK9 franchise and potentially reshaping the lipid-lowering market.

Full world state #12247 →